Cosmetic peptide
Argireline (Acetyl Hexapeptide-8, formerly Acetyl Hexapeptide-3) is a synthetic hexapeptide fragment of SNAP-25, a protein involved in neurotransmitter release and one of the targets of botulinum toxin. Marketed as a topical 'Botox alternative,' it is proposed to inhibit SNARE complex formation and reduce wrinkle depth. It is classified as an OTC cosmetic ingredient in the US and is widely used in anti-aging skincare formulations.
Present the limited clinical evidence without equating topical argireline to botulinum toxin injections. Do not publish dosing protocols or sourcing instructions. Track 'Botox alternative' claims against published clinical data.
A randomized, placebo-controlled study (n=60 Chinese subjects) showed that topical 10% acetyl hexapeptide-8 applied twice daily for 4 weeks reduced peri-orbital wrinkle depth, with both objective and subjective measures showing improvement (Wang et al., Am J Clin Dermatol, 2013).
A prospective, randomized controlled study evaluated the combination of tripeptide-10-citrulline and acetyl hexapeptide-3, showing improvements in skin roughness and wrinkle parameters (J Cosmet Dermatol, 2017).
Argireline is a fragment of SNAP-25 and is proposed to inhibit vesicle docking by preventing formation of the ternary SNARE complex, interfering with catecholamine release — a mechanism analogous to but distinct from botulinum toxin.
Argireline is classified as an OTC cosmetic ingredient in the US with no FDA drug approval. It is widely marketed as a topical anti-wrinkle ingredient.
Evidence level: Peer reviewed
Sources: PubMed / NCBI, Wikipedia
One RCT supports modest wrinkle reduction after 4 weeks of topical use. Do not equate to botulinum toxin injections, which have substantially stronger evidence. Track 'Botox alternative' claims carefully.
Evidence level: Preclinical
Sources: PubMed / NCBI, Wikipedia
The SNARE inhibition mechanism is proposed based on the peptide's relationship to SNAP-25. Clinical evidence for this mechanism in human skin is limited. Distinguish mechanistic rationale from proven clinical efficacy.
Evidence level: Market observation
Sources: Wikipedia, PubMed / NCBI
Track market availability without endorsing specific products. Argireline is a cosmetic ingredient, not an FDA-approved drug.
Source records are stored in the repo and linked from each claim.
Matrixyl (Palmitoyl Pentapeptide-4, formerly Palmitoyl Pentapeptide-3) is a matrikine peptide (Pal-KTTKS) used in anti-w...
Evidence review5-Amino-1MQ (5-amino-1-methylquinoline) is a small molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enz...
Regulatory watchAOD-9604 is a synthetic peptide corresponding to the C-terminal fragment of human growth hormone (hGH) residues 177-191,...
Regulatory watchBPC-157 is widely discussed online in injury recovery and performance communities, but the public evidence and regulator...
Regulatory watch